Happi Staff07.01.20
Addison, TX
www.marykay.com
Sales: $3 billion
Key personnel: David Holl, president and chief executive officer; Sheryl Adkins-Green, chief marketing officer; KK Chua, president, Asia Pacific; Tara Eustace, president, Europe; Deborah Gibbins, chief financial officer; Lucy Gildea, PhD, senior vice president, chief scientific officer; Chaun Harper, senior vice president, chief manufacturing officer; Kregg Jodie, chief information officer; Nathan Moore, president, North America; Melinda Foster Sellers, chief people officer; Julia A. Simon, chief legal officer and secretary; Jose Smeke, president, Latin America; Richard Rogers, executive chairman; Ryan Rogers, board of directors and chief investment officer
Major products: Skin care, color cosmetics, body care, sun care and fine fragrances marketed under the Mary Kay and TimeWise brand names
New products: Skin Care: Mary Kay TimeWise Miracle Set 3D. Body Care: White Tea & Citrus Satin Body Whipped Shea Créme. Color Cosmetics: Lash Love Fanorama mascara
Comments: Mary Kay is the largest US direct sales beauty company. The company recently opened its $100 million-plus manufacturing and research facility in Lewisville, TX. Last year, Mary Kay researchers focused on three pillars of skin health, including pollution, skin barrier health and sensitive skin. For example, at the 73rd Annual Meeting of the Society of Cosmetic Chemists in December, Dr. Lucy Gildea, chief scientific officer, Mary Kay, told attendees that new research suggests that microbes play an important role in overall skin health and that her company is heavily invested in microbe research.
“We have a commitment to take an active role in the beauty and scientific communities through participation in global dermatological conferences,” added Gildea.
MK executives were certainly on the road quite often in 2019 to discuss pollution, skin barrier health and sensitive skin. At Reunión Anual de Dermatólogos Latinamericanos (RADLA) in Buenos Aires, Gildea moderated a session with three Brazilian dermatologists who concluded that antioxidants are a viable way to counteract the negative effects of pollution on skin. A month later, Dr. Michelle Hines, global upstream research & technology, was at the 24th World Congress of Dermatology in Milan, where MK hosted a session with two dermatologists who discussed the impact of environmental stressors on skin. And in June, Hines detailed the benefits of Mary Kay TimeWise Miracle Set 3D skin care at the 5th Future Formulations in Cosmetics Summit in Dusseldorf.
Regarding skin barrier health and sensitive skin, in March, at the 20th World Dermatology Congress in Singapore, Senior Principal Scientist David Gan presented new insights in evaluating and understanding facial redness. Based on this work, Mary Kay scientists identified skin care technology that helps reduce production of pro-inflammatory proteins and enzymes skin and developed a cosmetic formulation containing these ingredients to effectively address facial redness using unique clinical measures. In August, Mary Kay China’s Senior Manager for Medical Affairs, Dr. Jenny Jiang, shared strategies to improve the skin barrier function and facial redness at the Annual Meeting of the Dermatology Committee organized by the Chinese Association of Integrative Medicine. And in November, Mary Kay sponsored the 44th annual meeting of The Japanese Society of Investigative Dermatology (JSID) in Aomori, Japan. Gildea moderated a symposium exploring environmental protection strategies against skin aging in Asians, protein response to skin inflammation and skin barrier defects. At the Skin of Color Society Symposium in Washington DC in March, Dr. Shoná Burkes-Henderson, associate principal scientist, clinical research, detailed research on navy bean extract and its ability to regulate melanogenesis to improve uneven skin tone and facial hyperpigmentation. Burkes-Henderson also presented an approach to improve facial erythema at the American Academy of Dermatology Annual Meeting.
In May, Associate Principal Scientist Dr. Tiffany Carle attended 77th Annual Meeting of the Society for Investigative Dermatology in Chicago, where she presented data from analyzing the effects of a serum containing five botanical fruit extracts known to be rich in vitamin C on skin appearance. As part of this study, Mary Kay researchers treated artificial skin tissue with this serum and utilized a genomic approach to understand how the serum affected the skin.
The following month, Mary Kay sponsored the University of the Philippines Medical Alumni Society of America (UPMASA) 34th Annual Grand Convention (AGC) in Dallas. The conference convened more than 500 doctors from the US and the Philippines to discuss topics ranging from dermatology to orthopedics and neurology.
In September, Mary Kay shared research targeting the causes and underlying mechanisms of slackened skin at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR) held in Bordeaux, France. Dr. Michelle Hines shared data on technology that targeted slackened skin leading to improvement in skin clinical measures.
www.marykay.com
Sales: $3 billion
Key personnel: David Holl, president and chief executive officer; Sheryl Adkins-Green, chief marketing officer; KK Chua, president, Asia Pacific; Tara Eustace, president, Europe; Deborah Gibbins, chief financial officer; Lucy Gildea, PhD, senior vice president, chief scientific officer; Chaun Harper, senior vice president, chief manufacturing officer; Kregg Jodie, chief information officer; Nathan Moore, president, North America; Melinda Foster Sellers, chief people officer; Julia A. Simon, chief legal officer and secretary; Jose Smeke, president, Latin America; Richard Rogers, executive chairman; Ryan Rogers, board of directors and chief investment officer
Major products: Skin care, color cosmetics, body care, sun care and fine fragrances marketed under the Mary Kay and TimeWise brand names
New products: Skin Care: Mary Kay TimeWise Miracle Set 3D. Body Care: White Tea & Citrus Satin Body Whipped Shea Créme. Color Cosmetics: Lash Love Fanorama mascara
Comments: Mary Kay is the largest US direct sales beauty company. The company recently opened its $100 million-plus manufacturing and research facility in Lewisville, TX. Last year, Mary Kay researchers focused on three pillars of skin health, including pollution, skin barrier health and sensitive skin. For example, at the 73rd Annual Meeting of the Society of Cosmetic Chemists in December, Dr. Lucy Gildea, chief scientific officer, Mary Kay, told attendees that new research suggests that microbes play an important role in overall skin health and that her company is heavily invested in microbe research.
“We have a commitment to take an active role in the beauty and scientific communities through participation in global dermatological conferences,” added Gildea.
MK executives were certainly on the road quite often in 2019 to discuss pollution, skin barrier health and sensitive skin. At Reunión Anual de Dermatólogos Latinamericanos (RADLA) in Buenos Aires, Gildea moderated a session with three Brazilian dermatologists who concluded that antioxidants are a viable way to counteract the negative effects of pollution on skin. A month later, Dr. Michelle Hines, global upstream research & technology, was at the 24th World Congress of Dermatology in Milan, where MK hosted a session with two dermatologists who discussed the impact of environmental stressors on skin. And in June, Hines detailed the benefits of Mary Kay TimeWise Miracle Set 3D skin care at the 5th Future Formulations in Cosmetics Summit in Dusseldorf.
Regarding skin barrier health and sensitive skin, in March, at the 20th World Dermatology Congress in Singapore, Senior Principal Scientist David Gan presented new insights in evaluating and understanding facial redness. Based on this work, Mary Kay scientists identified skin care technology that helps reduce production of pro-inflammatory proteins and enzymes skin and developed a cosmetic formulation containing these ingredients to effectively address facial redness using unique clinical measures. In August, Mary Kay China’s Senior Manager for Medical Affairs, Dr. Jenny Jiang, shared strategies to improve the skin barrier function and facial redness at the Annual Meeting of the Dermatology Committee organized by the Chinese Association of Integrative Medicine. And in November, Mary Kay sponsored the 44th annual meeting of The Japanese Society of Investigative Dermatology (JSID) in Aomori, Japan. Gildea moderated a symposium exploring environmental protection strategies against skin aging in Asians, protein response to skin inflammation and skin barrier defects. At the Skin of Color Society Symposium in Washington DC in March, Dr. Shoná Burkes-Henderson, associate principal scientist, clinical research, detailed research on navy bean extract and its ability to regulate melanogenesis to improve uneven skin tone and facial hyperpigmentation. Burkes-Henderson also presented an approach to improve facial erythema at the American Academy of Dermatology Annual Meeting.
In May, Associate Principal Scientist Dr. Tiffany Carle attended 77th Annual Meeting of the Society for Investigative Dermatology in Chicago, where she presented data from analyzing the effects of a serum containing five botanical fruit extracts known to be rich in vitamin C on skin appearance. As part of this study, Mary Kay researchers treated artificial skin tissue with this serum and utilized a genomic approach to understand how the serum affected the skin.
The following month, Mary Kay sponsored the University of the Philippines Medical Alumni Society of America (UPMASA) 34th Annual Grand Convention (AGC) in Dallas. The conference convened more than 500 doctors from the US and the Philippines to discuss topics ranging from dermatology to orthopedics and neurology.
In September, Mary Kay shared research targeting the causes and underlying mechanisms of slackened skin at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR) held in Bordeaux, France. Dr. Michelle Hines shared data on technology that targeted slackened skin leading to improvement in skin clinical measures.
